Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises by Dahham Alsoud, Séverine Vermeire, Bram Verstockt

Connect to this object online.

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis by Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen

Connect to this object online.

A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State by Tom M. Hillary, Tine Vanhoutvin, Miet Peeters, Maya Imbrechts, Thomas Vanassche, Marjan Garmyn, Séverine Vermeire

Connect to this object online.

Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases by Wannee Kantasiripitak, An Outtier, Sebastian G. Wicha, Alexander Kensert, Zhigang Wang, João Sabino, Séverine Vermeire, Debby Thomas, Marc Ferrante, Erwin Dreesen

Connect to this object online.

Assessment of the Microbiota in Microdissected Tissues of Crohn's Disease Patients by Gert De Hertogh, Bart Lemmens, Peter Verhasselt, Ronald de Hoogt, Xavier Sagaert, Marie Joossens, Gert Van Assche, Paul Rutgeerts, Severine Vermeire, Jeroen Aerssens

Connect to this object online.

Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus by Constance Carels, Lucas Wauters, An Outtier, Filip Baert, Peter Bossuyt, Arnaud Colard, Danny De Looze, Marc Ferrante, Alexander Goegebuer, Bruno Hauser, Robert Hilbrands, Ilse Hoffman, Bart Keymeulen, Isabelle Paquot, Isabelle Ruytjens, Marc Simoens, Clara Thienpont, Annelies Verreth, Bram Verstockt, Séverine Vermeire, Gigi Veereman

Connect to this object online.